BioSpace News Archive

Genesis Innovation Group’s cultivate(MD) Capital Fund II, LP, a fund focused on investments in early stage healthcare companies with innovative technologies, announces its investment into SpinTech.

Aurora Cannabis Inc. announced today that, further to its October 17, 2018 announcement that it had received a sales license from Health Canada permitting the sale of cannabis softgel capsules, the Company has commenced shipments for both the Canadian medical and adult-use markets.

In practice, FOLOTYN use has caused Grade 2 or higher oral mucositis in more than half of patients, potentially impacting treatment of relapsed or refractory Peripheral T-cell Lymphoma (PTCL)

Alteogen Inc. and Lynkogen Inc. today announced that they have expanded the scope of their exclusive option agreement. In addition to the originally announced GLP-1 mimetic fusion proteins, Lynkogen will also acquire exclusive rights to FGF21 fusions, including dual function FGF21/GLP-1 mimetic fusion protein.

Data in relapsed/refractory and newly diagnosed acute myeloid leukemia (AML) patients underscore clinical opportunities across multiple outcomes measures and subgroups

DEXTENZA® (dexamethasone ophthalmic insert) is the First Intracanalicular Insert Approved by the FDA for Drug Delivery

Company’s Lead Program, ALPN-101, Demonstrates Activity in Animal Models of Graft Versus Host Disease and Hemophagocytic Lymphohistiocytosis

Funds will accelerate clinical development of VAR 200, 2-hydroxypropyl-beta-cyclodexrtrin (2HPβCD), for treatment of focal segmental glomerulosclerosis (FSGS), a rare kidney disease

Khiron Life Sciences Corp. announced today that its wholly-owned subsidiary, Kuida Life Mexico S.A., has received approval from Mexico’s Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to import and commercialize three products of the Company’s Nutraceutical Line.

FSD Pharma Inc. announced today that the Company has traded over four Billion Class B subordinate voting shares in its first six months of trading on the Canadian Securities Exchange (“CSE”).